Entries tagged "Pfizer"

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Pfizer."

12 result(s) displayed (25 - 36 of 40)

Mood enhancers

Drug companies get a warm reception in the debt market these days. Continue reading

Posted on February 6, 2009 1:12 PM

Risk Arbitrage: Feb. 9, 2009

2009 has begun better than it might have on the M&A front. Continue reading

Posted on February 6, 2009 1:00 PM

Transactions: Feb. 9, 2009

In the boom, a bewildering number of markets seemed to merge to one Metamarket. Now that it's all fractured, putting it back together is quite a chore. Continue reading

Posted on February 6, 2009 12:59 PM

Abbott leads the biotech wave

Skadden's Brian McCarthy led a team advising AMO in its sale to Abbott Labs. Continue reading

Posted on January 23, 2009 12:43 PM

They need a new drug

Expect Big Pharma to go shopping in biotechland, but with an eye for fire sales. Continue reading

Posted on January 9, 2009 2:10 PM

Cravath helps J&J implant Mentor, Omrix

J&J's Mentor deal grew out of a realization during the Beijing Olympics of the market potential for cosmetic products in Asia. Continue reading

Posted on December 12, 2008 3:01 PM

This won't hurt a bit

An examination of U.S. healthcare under the Obama administration. Continue reading

Posted on November 14, 2008 3:15 PM

The Supreme question

Does the FDA trump the states? Continue reading

Posted on November 14, 2008 3:14 PM

Ad add

For years Japan's largest agency has tried to expand into the U.S., and now it tries again, buying a hot New York firm in a tough M&A market. Continue reading

Posted on November 14, 2008 3:07 PM

Bridge over troubled waters

California's stem cell institute has money to lend to biotech startups and, it hopes, lure VCs to the table. Continue reading

Posted on October 31, 2008 3:52 PM

ImClone

Massachusetts' State-Boston Pension Fund has stepped in with a lawsuit to block Eli Lilly's $6.5 billion deal for ImClone. Continue reading

Posted on October 27, 2008 4:35 PM

Risk Arb update

Uncertainty in banking and M&A credit markets have hammered share prices of targets of hostile bids, along with the broader stock market. Continue reading

Posted on September 26, 2008 5:15 PM

Movable Type search results powered by Fast Search